Bristol-Myers Squibb
BMY
#194
Rank
โ‚ฌ99.57 B
Marketcap
48,76ย โ‚ฌ
Share price
0.67%
Change (1 day)
25.32%
Change (1 year)

Revenue for Bristol-Myers Squibb (BMY)

Revenue in 2026 (TTM): โ‚ฌ41.39 Billion

According to Bristol-Myers Squibb's latest financial reports the company's current revenue (TTM ) is โ‚ฌ41.64 Billion. In 2025 the company made a revenue of โ‚ฌ41.02 Billion a decrease over the revenue in the year 2024 that were of โ‚ฌ46.41 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Bristol-Myers Squibb from 1996 to 2026

Annual revenue

Year Revenue Change
2026 (TTM) โ‚ฌ41.39 B0.89%
2025 โ‚ฌ41.02 B-11.61%
2024 โ‚ฌ46.41 B14.01%
2023 โ‚ฌ40.71 B-5.39%
2022 โ‚ฌ43.03 B5.06%
2021 โ‚ฌ40.95 B18.49%
2020 โ‚ฌ34.56 B48.11%
2019 โ‚ฌ23.33 B18.34%
2018 โ‚ฌ19.72 B13.89%
2017 โ‚ฌ17.31 B-6.25%
2016 โ‚ฌ18.46 B21.95%
2015 โ‚ฌ15.14 B16%
2014 โ‚ฌ13.05 B10.04%
2013 โ‚ฌ11.86 B-10.94%
2012 โ‚ฌ13.32 B-18.57%
2011 โ‚ฌ16.35 B11.68%
2010 โ‚ฌ14.64 B25.69%
2009 โ‚ฌ11.65 B-20.9%
2008 โ‚ฌ14.73 B17.66%
2007 โ‚ฌ12.52 B-7.77%
2006 โ‚ฌ13.57 B-16.27%
2005 โ‚ฌ16.21 B25.22%
2004 โ‚ฌ12.94 B-22.45%
2003 โ‚ฌ16.69 B-3.66%
2002 โ‚ฌ17.33 B-20.19%
2001 โ‚ฌ21.71 B7.27%
2000 โ‚ฌ20.24 B5.17%
1999 โ‚ฌ19.25 B24.94%
1998 โ‚ฌ15.40 B9.48%
1997 โ‚ฌ14.07 B10.86%
1996 โ‚ฌ12.69 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Johnson & Johnson
JNJ
โ‚ฌ82.76 B 98.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚ฌ48.59 B 16.70%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
โ‚ฌ54.38 B 30.59%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
โ‚ฌ52.53 B 26.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚ฌ62.05 B 49.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚ฌ31.96 B-23.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚ฌ47.63 B 14.39%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
โ‚ฌ8.53 B-79.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚ฌ56.48 B 35.65%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚ฌ51.91 B 24.66%๐Ÿ‡ฌ๐Ÿ‡ง UK